{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:51:57Z","timestamp":1793375517365,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL146691"],"award-info":[{"award-number":["R01-HL146691"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02964-6","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:38:54Z","timestamp":1762875534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A six-year longitudinal study identifies a statin-independent association between low LDL-cholesterol and risk of type 2 diabetes"],"prefix":"10.1186","volume":"24","author":[{"given":"Maria","family":"Lembo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Trimarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pacella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislovas S.","family":"Jankauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Piccinocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Piccinocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Morisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Virginia","family":"Manzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Santulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Trimarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"9716","key":"2964_CR1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet. 2010;375(9716):735\u201342.","journal-title":"Lancet"},{"issue":"5","key":"2964_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-8587(24)00040-8","volume":"12","author":"CTT Collaboration","year":"2024","unstructured":"Collaboration CTT. Electronic address cnoau, Cholesterol Treatment Trialists C: Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis. Lancet Diabetes Endocrinol. 2024;12(5):306\u201319.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9965","key":"2964_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","volume":"385","author":"DI Swerdlow","year":"2015","unstructured":"Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. Lancet. 2015;385(9965):351\u201361.","journal-title":"Lancet"},{"issue":"10","key":"2964_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jama.2015.1206","volume":"313","author":"J Besseling","year":"2015","unstructured":"Besseling J, Kastelein JJ, Defesche JC, Hutten BA, Hovingh GK. Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus. JAMA. 2015;313(10):1029\u201336.","journal-title":"JAMA"},{"issue":"2","key":"2964_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S2213-8587(16)30396-5","volume":"5","author":"AF Schmidt","year":"2017","unstructured":"Schmidt AF, Swerdlow DI, Holmes MV, Patel RS, Fairhurst-Hunter Z, Lyall DM, et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2017;5(2):97\u2013105.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"22","key":"2964_CR6","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","volume":"375","author":"BA Ference","year":"2016","unstructured":"Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med. 2016;375(22):2144\u201353.","journal-title":"N Engl J Med"},{"issue":"10","key":"2964_CR7","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.2337\/db19-1134","volume":"69","author":"YC Klimentidis","year":"2020","unstructured":"Klimentidis YC, Arora A, Newell M, Zhou J, Ordovas JM, Renquist BJ, et al. Phenotypic and genetic characterization of lower LDL cholesterol and increased type 2 diabetes risk in the UK biobank. Diabetes. 2020;69(10):2194\u2013205.","journal-title":"Diabetes"},{"issue":"4","key":"2964_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamacardio.2024.5072","volume":"10","author":"A Ravi","year":"2025","unstructured":"Ravi A, Koyama S, Cho SMJ, Haidermota S, Hornsby W, Ellinor PT, et al. Genetic predisposition to low-density lipoprotein cholesterol and incident type 2 diabetes. JAMA Cardiol. 2025;10(4):379\u201383.","journal-title":"JAMA Cardiol"},{"issue":"4","key":"2964_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/HYPERTENSIONAHA.124.23829","volume":"82","author":"B Song","year":"2025","unstructured":"Song B, Sun L, Qin X, Fei J, Yu Q, Chang X, et al. Associations of lipid-lowering drugs with blood pressure and fasting glucose: a Mendelian Randomization Study. Hypertension. 2025;82(4):743\u201351.","journal-title":"Hypertension"},{"key":"2964_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI183777","author":"V Trimarco","year":"2024","unstructured":"Trimarco V, Izzo R, Jankauskas SS, Fordellone M, Signoriello G, Manzi MV, et al. A six-year study in a real-world population reveals an increased incidence of dyslipidemia during COVID-19. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI183777.","journal-title":"J Clin Invest"},{"issue":"1","key":"2964_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s44324-025-00072-3","volume":"3","author":"V Trimarco","year":"2025","unstructured":"Trimarco V, Izzo R, Pacella D, Manzi MV, Jankauskas SS, Gallo P, et al. Aspirin reduces the risk of type 2 diabetes associated with COVID-19. NPJ Metab Health Dis. 2025;3(1):27.","journal-title":"NPJ Metab Health Dis"},{"key":"2964_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18010102","author":"V Russo","year":"2020","unstructured":"Russo V, Piccinocchi G, Mandaliti V, Annunziata S, Cimmino G, Attena E, et al. Cardiovascular comorbidities and pharmacological treatments of COVID-19 patients not requiring hospitalization. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph18010102.","journal-title":"Int J Environ Res Public Health"},{"key":"2964_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/nu14193916","author":"H Ullah","year":"2022","unstructured":"Ullah H, Esposito C, Piccinocchi R, De Lellis LF, Santarcangelo C, Minno AD, et al. Postprandial glycemic and insulinemic response by a brewer\u2019s spent grain extract-based food supplement in subjects with slightly impaired glucose tolerance: a monocentric, randomized, cross-over, double-blind, placebo-controlled clinical trial. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14193916.","journal-title":"Nutrients"},{"key":"2964_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102345","volume":"66","author":"R Izzo","year":"2023","unstructured":"Izzo R, Pacella D, Trimarco V, Manzi MV, Lombardi A, Piccinocchi R, et al. Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study. EClinicalMedicine. 2023;66:102345.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2964_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.56067","volume":"8","author":"AM Egan","year":"2025","unstructured":"Egan AM, Wood-Wentz CM, Mohan S, Bailey KR, Vella A. Baseline fasting glucose level, age, sex, and body mass indexand the development of diabetes in US adults. JAMA Netw Open. 2025;8(1):e2456067. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.56067.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"2964_CR16","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1124\/jpet.123.001878","volume":"388","author":"V Trimarco","year":"2024","unstructured":"Trimarco V, Izzo R, Gallo P, Manzi MV, Forzano I, Pacella D, et al. Long-lasting control of LDL cholesterol induces a 40% reduction in the incidence of cardiovascular events: new insights from a 7-year study. J Pharmacol Exp Ther. 2024;388(3):742\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"2964_CR17","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jama.2016.14568","volume":"316","author":"LA Lotta","year":"2016","unstructured":"Lotta LA, Sharp SJ, Burgess S, Perry JRB, Stewart ID, Willems SM, et al. Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis. JAMA. 2016;316(13):1383\u201391.","journal-title":"JAMA"},{"issue":"12","key":"2964_CR18","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/ng.3977","volume":"49","author":"DJ Liu","year":"2017","unstructured":"Liu DJ, Peloso GM, Yu H, Butterworth AS, Wang X, Mahajan A, et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nat Genet. 2017;49(12):1758\u201366.","journal-title":"Nat Genet"},{"issue":"5","key":"2964_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0022-2275(20)42221-7","volume":"21","author":"MS Brown","year":"1980","unstructured":"Brown MS, Goldstein JL. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res. 1980;21(5):505\u201317.","journal-title":"J Lipid Res"},{"issue":"11","key":"2964_CR20","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1161\/ATVBAHA.108.172288","volume":"28","author":"R Burkhardt","year":"2008","unstructured":"Burkhardt R, Kenny EE, Lowe JK, Birkeland A, Josowitz R, Noel M, et al. Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. Arterioscler Thromb Vasc Biol. 2008;28(11):2078\u201384.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"47","key":"2964_CR21","doi-asserted-by":"publisher","first-page":"48865","DOI":"10.1074\/jbc.M409699200","volume":"279","author":"S Benjannet","year":"2004","unstructured":"Benjannet S, Rhainds D, Essalmani R, Mayne J, Wickham L, Jin W, et al. NARC-1\/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J Biol Chem. 2004;279(47):48865\u201375.","journal-title":"J Biol Chem"},{"issue":"18","key":"2964_CR22","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1073\/pnas.0402133101","volume":"101","author":"KN Maxwell","year":"2004","unstructured":"Maxwell KN, Breslow JL. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc Natl Acad Sci U S A. 2004;101(18):7100\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2964_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134725","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Jebari S, Larrea-Sebal A, Uribe KB, Siddiqi H, Ostolaza H, et al. Statin treatment-induced development of type 2 diabetes: from clinical evidence to mechanistic insights. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21134725.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2964_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13098-024-01477-8","volume":"16","author":"YY Zhang","year":"2024","unstructured":"Zhang YY, Chen BX, Wan Q. Association of lipid-lowering drugs with the risk of type 2 diabetes and its complications: a mendelian randomized study. Diabetol Metab Syndr. 2024;16(1):240.","journal-title":"Diabetol Metab Syndr"},{"key":"2964_CR25","doi-asserted-by":"crossref","unstructured":"Santulli G, Kansakar U, Jankauskas SS, Varzideh F: Comparative LDL-C Lowering Efficacy of Non-Statin Therapies: Inclisiran is Better than Ezetimibe, PCSK9 inhibitors, and Bempedoic Acid. J Cardiovasc Pharmacol 2025.","DOI":"10.1097\/FJC.0000000000001731"},{"issue":"20","key":"2964_CR26","doi-asserted-by":"publisher","first-page":"18368","DOI":"10.1074\/jbc.M300102200","volume":"278","author":"ME Roehrich","year":"2003","unstructured":"Roehrich ME, Mooser V, Lenain V, Herz J, Nimpf J, Azhar S, et al. Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J Biol Chem. 2003;278(20):18368\u201375.","journal-title":"J Biol Chem"},{"issue":"9","key":"2964_CR27","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1210\/en.2002-220273","volume":"143","author":"M Cnop","year":"2002","unstructured":"Cnop M, Hannaert JC, Grupping AY, Pipeleers DG. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology. 2002;143(9):3449\u201353.","journal-title":"Endocrinology"},{"issue":"10","key":"2964_CR28","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1210\/en.2009-0252","volume":"150","author":"S Rutti","year":"2009","unstructured":"Rutti S, Ehses JA, Sibler RA, Prazak R, Rohrer L, Georgopoulos S, et al. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology. 2009;150(10):4521\u201330.","journal-title":"Endocrinology"},{"issue":"8","key":"2964_CR29","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0022-2275(20)31566-2","volume":"42","author":"JF Oram","year":"2001","unstructured":"Oram JF, Lawn RM. ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J Lipid Res. 2001;42(8):1173\u20139.","journal-title":"J Lipid Res"},{"issue":"3","key":"2964_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nm1546","volume":"13","author":"LR Brunham","year":"2007","unstructured":"Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, Vasanji Z, et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med. 2007;13(3):340\u20137.","journal-title":"Nat Med"},{"issue":"3","key":"2964_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2337\/db11-0944","volume":"61","author":"N Wijesekara","year":"2012","unstructured":"Wijesekara N, Zhang LH, Kang MH, Abraham T, Bhattacharjee A, Warnock GL, et al. Mir-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes. 2012;61(3):653\u20138.","journal-title":"Diabetes"},{"issue":"4","key":"2964_CR32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2337\/dc09-1562","volume":"33","author":"M Vergeer","year":"2010","unstructured":"Vergeer M, Brunham LR, Koetsveld J, Kruit JK, Verchere CB, Kastelein JJ, et al. Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction. Diabetes Care. 2010;33(4):869\u201374.","journal-title":"Diabetes Care"},{"issue":"3","key":"2964_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101010","volume":"297","author":"P Suresh","year":"2021","unstructured":"Suresh P, Miller WT, London E. Phospholipid exchange shows insulin receptor activity is supported by both the propensity to form wide bilayers and ordered raft domains. J Biol Chem. 2021;297(3):101010.","journal-title":"J Biol Chem"},{"issue":"1","key":"2964_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12944-025-02563-0","volume":"24","author":"M Warda","year":"2025","unstructured":"Warda M, Tekin S, Gamal M, Khafaga N, Celebi F, Tarantino G. Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases. Lipids Health Dis. 2025;24(1):147.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"2964_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11883-012-0299-z","volume":"15","author":"K Axsom","year":"2013","unstructured":"Axsom K, Berger JS, Schwartzbard AZ. Statins and diabetes: the good, the bad, and the unknown. Curr Atheroscler Rep. 2013;15(2):299.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"2964_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2012.06.001","volume":"13","author":"N Sattar","year":"2012","unstructured":"Sattar N, Taskinen MR. Statins are diabetogenic\u2013myth or reality? Atheroscler Suppl. 2012;13(1):1\u201310.","journal-title":"Atheroscler Suppl"},{"issue":"11","key":"2964_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jacasi.2024.07.011","volume":"4","author":"J Lu","year":"2024","unstructured":"Lu J, Liu Y, Wang Z, Zhou K, Pan Y, Zhong S, et al. Genetic associations of lipids and lipid-modifying drug targets with type 2 diabetes in the Chinese population. JACC Asia. 2024;4(11):825\u201338.","journal-title":"JACC Asia"},{"issue":"1","key":"2964_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12933-021-01283-w","volume":"20","author":"LT Fischer","year":"2021","unstructured":"Fischer LT, Hochfellner DA, Knoll L, Pottler T, Mader JK, Aberer F. Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):89.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2964_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.clinthera.2021.12.005","volume":"44","author":"BH Marouf","year":"2022","unstructured":"Marouf BH, Iqbal Z, Mohamad JB, Bashir B, Schofield J, Syed A, et al. Efficacy and safety of PCSK9 monoclonal antibodies in patients with diabetes. Clin Ther. 2022;44(2):331\u201348.","journal-title":"Clin Ther"},{"key":"2964_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2019.07.023","volume":"289","author":"MB Morelli","year":"2019","unstructured":"Morelli MB, Wang X, Santulli G. Functional role of gut microbiota and PCSK9 in the pathogenesis of diabetes mellitus and cardiovascular disease. Atherosclerosis. 2019;289:176\u20138.","journal-title":"Atherosclerosis"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02964-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02964-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:38:55Z","timestamp":1762875535000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02964-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2964"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02964-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Board at the \u201cASL Napoli 1 Centro\u201d reviewed and approved this study organized with the patronage of the Italian Society for Cardiovascular Prevention (SIPREC) and granted a waiver of informed consent (Protocol# 257\/22\u201323). The investigation conforms to the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"429"}}